Home › Compare › ELOX vs VICI

ELOX vs VICI: Dividend Comparison 2026

ELOX yields 2475.25% · VICI yields 5.88%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ELOX wins by $73382614261.75M in total portfolio value
10 years
ELOX
ELOX
● Live price
2475.25%
Share price
$0.08
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$73382614261.78M
Annual income
$67,980,042,160,694,380.00
Full ELOX calculator →
VICI
VICI Properties Inc.
● Live price
5.88%
Share price
$28.90
Annual div
$1.70
5Y div CAGR
8.1%
Payout ratio
74%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$2,376.06
Full VICI calculator →

Portfolio growth — ELOX vs VICI

📍 ELOX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodELOXVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ELOX + VICI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ELOX pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ELOX
Annual income on $10K today (after 15% tax)
$210,396.04/yr
After 10yr DRIP, annual income (after tax)
$57,783,035,836,590,220.00/yr
VICI
Annual income on $10K today (after 15% tax)
$500.00/yr
After 10yr DRIP, annual income (after tax)
$2,019.65/yr
At 15% tax rate, ELOX beats the other by $57,783,035,836,588,210.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ELOX + VICI for your $10,000?

ELOX: 50%VICI: 50%
100% VICI50/50100% ELOX
Portfolio after 10yr
$36691307130.90M
Annual income
$33,990,021,080,348,380.00/yr
Blended yield
92.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

ELOX
Analyst Ratings
8
Buy
3
Hold
Consensus: Buy
Altman Z
-94.4
Piotroski
2/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+9.3% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ELOX buys
0
VICI buys
0
No recent congressional trades found for ELOX or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricELOXVICI
Forward yield2475.25% ✓5.88%
Annual dividend / share$2.00 ✓$1.70
Payout ratio50% ✓74%
1-year div growth0%6.3% ✓
5-year div CAGR0%8.1% ✓
Portfolio after 10y$73382614261.78M ✓$30.3K
Annual income after 10y$67,980,042,160,694,380.00 ✓$2,376.06
Total dividends collected$73004868605.64M ✓$13.2K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: ELOX vs VICI ($10,000, DRIP)

YearELOX PortfolioELOX Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$258,225$247,524.75$11,056$635.88+$247.2K → ELOX
2$6,249,854$5,973,553.08$12,250$729.34+$6.24M → ELOX
3$141,807,743$135,120,399.71$13,602$838.33+$141.79M → ELOX
4$3,017,015,462$2,865,281,177.24$15,139$965.75+$3017.00M → ELOX
5$60,200,153,348$56,971,946,803.11$16,890$1,115.11+$60200.14M → ELOX
6$1,126,836,870,511$1,062,422,706,429.18$18,890$1,290.64+$1126836.85M → ELOX
7$19,791,333,921,123$18,585,618,469,676.22$21,181$1,497.50+$19791333.90M → ELOX
8$326,252,175,090,930$305,075,447,795,328.50$23,813$1,741.95+$326252175.07M → ELOX
9$5,049,132,804,749,982$4,700,042,977,402,686.00$26,845$2,031.67+$5049132804.72M → ELOX
10$73,382,614,261,776,860$67,980,042,160,694,380.00$30,348$2,376.06+$73382614261.75M → ELOX

ELOX vs VICI: Complete Analysis 2026

ELOX — Stock

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts.

Full ELOX Calculator →

VICI — REIT

VICI Properties is a gaming and entertainment REIT owning properties including Caesars Palace and MGM Grand in Las Vegas. Its triple-net leases with leading casino operators provide highly predictable income. VICI has grown its dividend 8%+ annually since its 2018 IPO, making it one of the fastest-growing REITs.

Full VICI Calculator →
📬

Get this ELOX vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ELOX vs SCHDELOX vs JEPIELOX vs OELOX vs KOELOX vs MAINELOX vs NNNELOX vs EPRTELOX vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.